$ELV News

Implied Volatility Surging for Elevance Health Stock Options

ELV vs. RVTY: Which Stock Is the Better Value Option?

TD Cowen Maintains Buy on Elevance Health, Raises Price Target to $495

Elevance Health (ELV) Stock Rallies As Q3 Results Tighten Margin Focus

UBS Maintains Buy on Elevance Health, Raises Price Target to $523

Guggenheim Maintains Buy on Elevance Health, Raises Price Target to $485

Morgan Stanley Maintains Equal-Weight on Elevance Health, Raises Price Target to $449

RBC Capital Maintains Sector Perform on Elevance Health, Raises Price Target to $455

Barclays Maintains Overweight on Elevance Health, Raises Price Target to $472

ELV Q3 deep dive: Carelon expansion and Medicaid margin actions underpin raised outlook

Baird Maintains Neutral on Elevance Health, Raises Price Target to $406

Elevance: 3 Key Takeaways for Long-Term Investors

Elevance Health (ELV) Names Jeff Park Carelon President In Services Leadership Shift

2 Healthcare Stocks to Buy After Crushing Q3 Earnings Expectations: ELV & ISRG

Elevance Health, Inc. (ELV) Hits Fresh High: Is There Still Room to Run?

Elevance (ELV) Q3 2026 Earnings Call Transcript

Elevance Health Inc. Q3 2026 Earnings Call Summary

What Elevance Health (ELV) Said on Its Q3 Earnings Call

Elevance Health Posts Earnings Beat, Lifts Guidance. CFO Sees a ‘Clear Path’ to Growth.

ELV Beats Q3 Earnings Estimates on Carelon Strength, Raises 2026 Outlook